Mbah Inaugurates Multi-Billion Naira Pharmaceutical Plant in Enugu, Eyes Local Drug Supply Deal
The News Agency of Nigeria (NAN) reports that the private-sector investment is expected to contribute to Nigeria’s pharmaceutical industry while creating employment opportunities and promoting skills development.
Speaking at the inauguration on Thursday, Mbah described the facility as more than a pharmaceutical business, saying it represented an investment in public health, economic growth and the future of young people in the state.
The governor congratulated the company’s founder, board and management, noting that establishing a manufacturing enterprise required substantial commitment and confidence in Enugu’s economic prospects.
He said the facility would create jobs, offer internship opportunities and facilitate skills transfer, while supporting healthcare delivery across the state.
Mbah also disclosed that the state government would explore commercial partnerships with the company to supply medicines to its central medical stores and primary healthcare facilities.
He explained that the government was constructing 260 Type-2 primary healthcare centres, which would require reliable supplies of essential medicines to operate effectively.
“We are interested in made-in-Enugu, and that’s what you’re doing here,” he said, reaffirming his administration’s commitment to working with private enterprises beyond providing an enabling business environment.
The governor added that private capital investment remained central to the state’s economic growth strategy, stressing the need to create opportunities for young people to build their careers in Enugu rather than seek opportunities elsewhere.
In his remarks, the Chairman of the company’s Board of Directors, Rear Admiral Allison Madueke (Rtd), commended Mbah for creating an investment-friendly environment in the state.
He described Anchorage as a legacy project designed to generate employment, develop local talent and contribute to economic development.
Madueke said the company reflected his longstanding belief that private enterprise could create jobs, expand economic opportunities and improve prosperity.
The former Chief of the Naval Staff assured that the company would prioritise product quality, patient safety, regulatory compliance and sound corporate governance.
He also acknowledged the role of the National Agency for Food and Drug Administration and Control (NAFDAC) in safeguarding public health.
Madueke expressed confidence that Anchorage would contribute to the development of Enugu State, the South-East and Nigeria, while thanking the governor for inaugurating the facility and developing resilient, business-friendly infrastructure.
Also speaking, the Managing Director of the company, Mr Chima Madueke, said Anchorage was founded on the principles of quality and wellness, encapsulated in its slogan, “Anchored in Quality, Committed to Wellness.”
He said the company had obtained the necessary approvals and clearances from NAFDAC and the Pharmaceutical Society of Nigeria (PSN), reaffirming its commitment to quality assurance.
According to him, the pharmaceutical plant would help tackle the circulation of fake and substandard medicines in Nigeria.
He added that the company was open to supplying medicines directly to hospitals, healthcare institutions and pharmacies.
